Agrin, a component of the synaptic basal lamina, has been shown to induce clustering of ACh receptors on the surface of muscle fibers. Analysis of cDNAs isolated from a rat embryonic spinal cord library demonstrated that agrin contains domains similar to regions of protease inhibitors, laminin and epidermal growth factor. The domain structure of agrin is further revealed here in an analysis of the agrin gene. Two additional internal repeated sequences are defined: one rich in cysteine residues with no homology to other proteins, and another similar to the laminin G domain, which is involved in heparin binding. Alternative RNA splicing at two positions in the gene predicts up to eight possible forms of the agrin protein. The gene (symbol AGRN/Agrn) has been assigned to chromosome 1 region pter-p32 in human and to mouse chromosome 4.
Interactions between cells and components of the extracellular matrix mediate aspects of growth, migration, and differentiation. In the nervous system, the extracellular matrix of the neuromuscular junction is enriched in molecules that may have important roles in synaptic function and development (Hall, 1973; Bayne et al., 1984; Hunter et al., 1989) . One of these synaptic matrix proteins, agrin, was recognized for its ability to induce clusters of ACh receptors (AChRs) when applied to muscle fibers in culture (Godfrey et al., 1984; Fallon et al., 1985; Nitkin et al., 1987) . Early in development, AChRs are randomly distributed along muscle fibers. However, as nerve-muscle contacts are made, receptors redistribute beneath the presynaptic terminal in a position appropriate for neurotransmitter response Salpeter, 1974, 1976; Anderson et al., 1977; Bevan and Steinbach, 1977; Weinberg et al., 198 I; Schuetze and Role, 1987) . The results obtained with agrin from marine ray electric organ and recombinant sources suggest that it may mediate this nerve-induced receptor clustering on developing muscle fibers. Agrin is synthesized in the nerve cell body (Magill-Sole and McMahan, 1988; Rupp et al., 1991) is transported down the axon via anterograde transport (Magill-Sole and McMahan, 1990) and is specifically localized to the synaptic basal lamina. Agrin-induced clusters of AChR also contain high concentrations of AChE, heparan sulfate proteoglycan, and a 43 kDa protein, suggesting that agrin may regulate the organization of multiple synaptic components (Wallace, 1986 (Wallace, , 1989 McMahan and Wallace, 1989; Nitkin and Rothschild, 1990) . The presence of agrin immunoreactivity in the basal lamina of damaged synapses suggests that agrin may also play a role in the regeneration of the neuromuscular junction (Reist et al., 1987) .
The mechanism of agrin action is unknown. However, recent studies suggest that (1) in chick, phosphorylation of tyrosine residues in the P-subunit of the ACh receptor precedes aggregation (Peng et al., 1991; Qu et al., 1991; Wallace et al., 1991) and (2) a 43 kDa protein associated with the intracellular aspect of the AChR promotes clustering (Froehner et al., 1990; Froehner, 1991; Phillips et al., 1991) . Thus, agrin may act through tyrosine kinase(s) and the 43 kDa protein to localize AChR at synaptic sites.
One approach to understand further the function of agrin during synapse formation and regeneration is analysis of the amino acid sequence. To this end, Rupp et al. (199 1) characterized a set of clones isolated from an embryonic spinal cord cDNA library. The protein predicted from analysis of these clones contains an N-terminal hydrophobic sequence that may act as a signal peptide. The agrin protein is composed of several domains, including nine regions homologous to Kazal-type protease inhibitors, a region showing significant amino acid identity with the extracellular matrix protein laminin, two serine/threonine-rich domains that may be sites of O-linked glycosylation, and four regions similar to repeats found in epidermal growth factor (EGF). A 9 amino acid sequence was found to be present in one set of clones and absent from another, suggesting alternative RNA splicing may generate multiple agrin proteins. Northern blotting and in situ hybridization demonstrated that the transcript is most abundant in the embryonic nervous system, including motor neurons. Lower transcript levels are also found in embryonic muscle. Agrin immunoreactivity was shown to be localized to the synaptic cleft of the rat neuromuscular junction, where the protein appears as an approximately 2 10 kDa species in Western blotting experiments (Rupp et al., 199 1) .
The full-length rat agrin protein has been expressed in CHO and COS cells. In these transfected cells, immunoreactivity is detected in the endoplasmic reticulum and Golgi region, as well as the extracellular surface where the protein is associated with extracellular matrix. When the agrin-transfected cells are cocultured with rat muscle fibers, AChRs are localized at high density to transfected cell-muscle cell contact sites (Campanelli et al., 1991) . Together, these data suggest that agrin mediates the neuron-induced clustering of AChR at synaptic sites during development (McMahan and Wallace, 1989; Campanelli et al., 1991; Rupp et al., 1991) .
In the present study, we further define the domain structure of alternatively spliced agrin proteins. The genomic organization underlying the alternative splicing is presented along with the chromosomal location of the gene in mouse and human.
Materials and Methods
PCR reactions and alternative splicing. The numbering of bases and amino acids is as described in Rupp et al. (I 99 1) . Single-stranded cDNA (ss cDNA, 0.1 fig) was synthesized from rat embryonic day 17 spinal cord polyA+ RNA using Moloney murine leukemia virus reverse transcriptase, as recommended by the manufacturer (Bethesda Research Labs). PCR reactions were performed in 1 x PCR buffer (Perkin Elmer Cetus), 10 U of Taq polymerase (Perkin Elmer Cetus), and 0.2 FM concentrations of each primer using 0.5 ng of ss cDNA preheated 5 min at 97°C. The primers correspond to rat agrin nucleotides 5184-5204 and to the reverse complement of rat agtin nucleotides 60 16-6034 with an added XbaI restriction site at the 3' end. The amplification protocol was 60 cycles of I. 15 min denaturing steps at 94"C, followed by extension steps of 2.3 min at 72°C. The PCR products were separated on a 2% agarose gel and purified following the Geneclean protocol (Bio 101). Aliquots of the purified PCR products were subcloned into Bluescript KS-(Stratagene). Combinations of internal primers were used to amplify ahquots of purified PCR products further. The primers were from rat agrin nucleotides 5392-54 I 1, and reverse complement nucleotides 5792-58 11. The amplification conditions were the same as de&bed above, except the extension was done in two steps of 1.15 min each at 60°C and 72°C. The reamplified PCR products were separated on a 2.2% agarose gel, purified, subcloned into Bluescript KS-, and sequenced using the Sequenase 2 kit (U.S. Biochemicals).
Oligonucleotides specific for the 8 and the 11 amino acid differentially spliced exons were used to screen the original PCR product subclones. Hybridizations were performed at 57°C in 5~ saline-sodium citrate (SSC), 5 x Denhardt's solution, 0.5% SDS, 150 &ml Escherichia coli tRNA (Sigma), and IO6 cpm/mI of a 4 x IO6 cpm/pmoI labeled oligonucleotide. About 2.5% of the total colonies were positive for either probe.
Genomic library screening and sequencing. Plaques (500,000) of a lambda Fix11 genomic library constructed with DNA isolated from a mouse PCC4 cell line (Stratagene) were screened using a rat agrin cDNA probe (nucleotides 34 14-4069). Hybridization was carried out overnight at 55°C in 5 x SSC, 5 x Denhardt's solution, 0.5% SDS, and I50 &ml tRNA. The filters were washed once for 10 min at room temperature in 1 x SSC, 0.1% SDS and twice for 20 min at 55°C with 0.1 x SSC, 0.1% SDS. Digestion of the positive clone with Not1 revealed a 16 kilobase (kb) insert. After further digestion with Hind111 and BamHI restriction enzymes, five fragments were obtained. In the 5' to 3' direction, the fragments were N/B (1.5 kb), B/B (2.5 kb), B/H (5.4 kb), H/H (4.8 kb), and H/N (1.8 kb), respectively (see Fig. 3 ). These fragments were individually subcloned into the Bluescript KS+ vector from Stratagene. CsCl-prepared DNA from the recombinant plasmid was sequenced using the dideoxy chain termination method with the Sequenase kit. Both oligonucleotides specific for the rat agrin cDNA clone and for the mouse genomic clone were used as primers in the sequencing reactions.
cDNA library screening and sequencing. A human agrin cDNA clone was obtained by screening 500,000 plaques of a lambda Zap11 cDNA library constructed from human fetal brain cDNA (Stratagene). A rat agrin cDNA, as above, was used as a probe. Hybridization was carried out overnight at 60°C in the same hybridization buffer as described above. The filters were washed once for 20 min at 60°C in 1 x SSC, 0. I % SDS and once for 20 min at 60°C in 0.1 x SSC, 0.1% SDS. An insert from a positive agrin clone was isolated by in vivo excision of the Bluescript plasmid from the lambda Zap11 vector and shown to contain a 5.2 kb insert. The insert was partially sequenced by the dideoxy chain termination method revealing strong identity with the nucleotide and predicted amino acid sequence of rat agrin.
Hybrid cell lines. The chromosomal location of the human agrin gene has been determined by Southern blot analysis using a 2.1 kb Not1 subclone of the human agrin cDNA clone. The probe was hybridized to a human mapping panel of 14 Chinese hamsier x human somatic cell hvbrids from series XII. XV. XVII. XVIII. XXI. and 3 1. The mouse gene was assigned with a mouse mapding panel of i 2 Chinese hamster x mouse hybrids from fusions I, EAS, and EBS. The hybrid that was used for the regional assignment in human was from fusion of human cells with a balanced reciprocal translocation t( 1;6) (~32; p2 1) (hybrid series XV). The derivation of hybrid cell lines has been summarized elsewhere . Five different inbred mouse strains, AKR/J, C3H/HeJ, C57BL/6J, C57L/J, and DBA/ZJ from The Jackson Laboratory, Bar Harbor, ME, were used for polymorphism search with the agrin probe.
Southern blot hybridization. Genomic DNA was extracted from hybrids and parental control cell lines by standard methods. DNA samples were digested with restriction endonucleases, separated by agarose gel electrophoresis, transferred to Hybond nylon filters (Amersham), and hybridized to 32P-labeled probes according to methods described elsewhere (Barton et al., 1986) .
Results
Multiple forms of agrin are expressed in embryonic spinal cord.
Analysis of agrin cDNA clones isolated from an embryonic spinal cord library revealed two forms differing by 9 amino acids ( Fig. 1A) (Rupp et al., 199 1) . Since the remainder of overlapping sequence from these clones is identical, the difference is most likely the result of alternative RNA splicing. In addition, a variety of cDNA clones encoding multiple agrin-related proteins have been isolated from chicken cDNA libraries (McMahan, 1990) . To characterize forms of mammalian agrin further, PCR was used to amplify cDNA synthesized from rat embryonic day 17 spinal cord RNA. Sequence analysis of a set of the cloned PCR products predicts four forms of agrin (Fig. 1B) . The forms differ at amino acid 1779, where four variations in sequence are identified: (1) no insert sequences, (2) an 8 amino acid insert, (3) an 11 amino acid insert, or (4) a 19 amino acid insert consisting of both the 8 and the 11 amino acid sequences. Each of these variants has been observed in multiple independent clones.
At this stage of rat development, about 90% of all agrifl transcripts in spinal cord encode the variant lacking additional sequences at amino acid position 1779. The other three variants represent about 10% of the agrin cDNA in embryonic spinal cord (data not shown). The sequences inserted at position 1779 contain charged amino acids, as well as several proline residues. The polar character of the inserts suggests that they lie on the surface of the molecule. The prolines do not favor helical structures. Since the identification of these sequence variants comes from partial cDNA clones or PCR products, we have not yet determined whether all of the eight possible combinations of sequences occur in vivo.
Organization of the agrin gene. To understand better the domain structure and the mechanism underlying the synthesis of alternative forms of agrin, we isolated and characterized most of the coding region of the mouse agrin gene. The mouse genomic clone we have characterized is a 16 kb Not1 restriction enzyme fragment and was shown by Southern blotting experiments to contain sequences homologous to most of the rat cDNA. Five subfragments of the Not1 fragment were subcloned and the nucleotide sequence of each determined, as described in Materials and Methods. The genomic fragment contains 36 exons beginning at the first protease inhibitor domain and extending through the 3' untranslated region. We have not found the exon sequences predicted to encode the initiator methionine and the signal sequence. This suggests an intron greater than 1.35 kb separates this region of the gene from the main body of coding sequences. With the exception of the 3' untranslated region, the exons are quite small; the largest is 333 base pairs while the smallest is 12 base pairs. Similarly, the introns are also generally small; the largest intron is only 7 12 base pairs, while the smallest is 65 base pairs.
The intron/exon pattern of the agrin gene displays a remark-
able correspondence to the previously suggested domain structure of the protein (Figs. 2, 3) (Rupp et al., 199 1) . The first seven protease inhibitor domains are each encoded on separate exons. Protease inhibitor domains 8 and 9 are also flanked by introns, but also contains an intron within the domain. The relative position of this "internal" intron is identical, even though the degree of amino acid identity between these exons is no greater than that between protease inhibitor domains 1-7, which do not contain an internal intron. Exon number 10 (39 amino acids) displays 22% amino acid sequence identity to exon number 16 (46 amino acids). Alignment of the carboxy terminal amino acids of these two exons demonstrates that 10 amino acids occur in identical positions (Fig. 4A ). Of these 10 identical positions, four are cysteine residues and three are proline residues. These domains do not show any significant homology to other proteins in the data base. However, the identical locations of the cysteine and proline residues suggest that they may participate in creating a repetitive tertiary structure.
The carboxy terminal 800 amino acids contain three additional repeated sequences. These 110 amino acid sequences share extensive amino acid identity and similarity (Fig. 4B) , clearly demonstrating that internal duplications have contributed to the evolution of this portion of the agrin protein. The first and third repeats are each encoded on two exons; 21-22 and 35-36, respectively. The second repeat contains 4 amino acids that are not found in repeats 1 and 3. These amino acids are encoded on a distinct exon (exon 28) and thus repeat 2 is encoded on a total of 4 exons (exons 26-29) (Fig. 4B) . The 4 amino acid exon is the smallest in the gene and encodes the sequence KSRK. Surprisingly, these repeated regions share significant sequence homology with the G domain of the laminin A chain (Sasaki et al., 1988) and with merosin (Ehrig et al., 1990) . Both merosin and laminin A contain five internal repeated regions denoted G l-G5. The three agrin repeated regions share highest homology to laminin A Gl and G2, and to merosin Gl, G2, and G4 domains.
Exons 11 and 12 encode a cysteine-rich region of the agrin protein that is similar to type A repeats in laminin domain III. We proposed that this region evolved through an internal duplication, a hypothesis that is supported by the genomic organization (Rupp et al., 1991) . The first of two set-me-and thre- The amino acid number is written above the sequence and the nucleotide sequence is written below according to Rupp et al. (199 1) . A, Two variants differing by 9 amino acids are found at amino acid position 1143. B, Four alternative sequences are observed at position 1779. One variant contains an insert of 8 amino acids, a second variant has an insert of 1 I amino acids, while a third variant contains a I9 amino acid insert that comprises the 8 and the 11 amino acid sequences.
onine-rich regions is encoded by a distinct exon (exon 15) whereas the second is encoded by an exon that also contains the first EGF-repeat sequence (exon 20). The serine-and threonine-rich regions have been suggested to be O-linked glycosylation cassettes. While we do not have information regarding their specific function, the genomic organization supports a hypothesis that these regions of the molecule have distinct functions. The remaining three EGF-repeat sequences are not encoded on distinct exons; however, EGF repeats 3 and 4 contain intervening sequences at their carboxy terminal aspect. The carboxy terminal 52 amino acids are coded by a single exon that includes the 3' untranslated portion of the mRNA.
Alternative RNA splicing generates mdtipk forms qf agrin. Many extracellular matrix protein isoforms are generated by alternative RNA splicing. Examples include elastin (Indik et al., 1987) fibronectin (Komblihtt et al., 1985; Schwarzbauer et al., 1987) and collagen (Pihlajaniemi et al., 1987; Tikka et al., 1987; Svoboda et al., 1988; Ryan and Sandell, 1990) . In addition, some of the splicing patterns display species and tissue specificity (see Andreadis et al., 1987 , for a review). Indeed the differences in the predicted agrin protein sequences described above arise from two different modes of alternative RNA splicing. The donor site of exon 19 can be spliced to either of two receptor sites separated by nine amino acids on exon 20 (Figs. 2, 3) . Four possibilities arise for the splicing of exons 31, 32, 33, and 34 (Figs. 2, 3) . Exon 3 1 can be directly joined to exon 34, skipping the sequences encoded by exons 32 and 33. This splices out the longest intervening sequence ofthe coding region. Alternatively, exon 3 1 can be spliced to exon 32 and then to 34, skipping exon 33, or exon 3 1 can be spliced to exon 33 and then to 34, skipping exon 32. These patterns give rise to the 8 and the 11 amino acid inserts detected in the PCR amplification of embryonic spinal cord cDNA. The final pattern is generated by joining exons 3 1, 32, 33, and 34 in sequence and accounts for the 19 amino acid sequence found in the spinal cord cDNA.
Isolation of a human agrin cDNA. Since the mouse genomic fragment used to probe the human chromosome mapping blots hybridized weakly, we isolated a human agrin cDNA clone from an embryonic brain cDNA library (see Materials and Methods). To confirm the identity of the human cDNA clone, the nucleotide sequence was determined using the T7 primer. The region sequenced was at the 5' end of the cDNA and encodes 6 1 amino acids. In the 188 nucleotides of sequence obtained, there are 29 differences from the rat cDNA; 4 occur in the first codon position, 6 occur in the second codon position, and 19 occur in the third position (Fig. 5) . These substitutions result in nine predicted amino acid replacements.
Interestingly, four of the amino acid replacements have two or more nucleotide substitutions, while five are the result of only a single base change. The region sequenced corresponds to protease inhibitor domain 7, which may be particularly highly conserved when compared to other domains of the molecule. The data demonstrate that we have indeed isolated a human agrin homolog useful for chromosome mapping experiments.
Mapping of human agrin. The human agrin gene (gene symbol AGRN) was mapped with a BamHI-digested mapping panel of Chinese hamster x human somatic cell hybrids that carry reduced numbers of human chromosomes.
The 2.1 kb human probe hybridizes to an 11 kb human and an 8 kb Chinese hamster fragment (Fig. 6, left, lanes 1 and 2, respectively) . The 11 kb human fragment was concordant with human chromosome 1. All other chromosomes were excluded by at least two discordant hybrids (Table 1) . One hybrid cell line from fusion series XV that carried human chromosome 1 region p32-qter, in the absence of an intact copy of this chromosome, was negative for the human signal. Therefore, we assign the AGRN locus to the distal short arm region lpter-p32.
Mapping of mouse agrin. Hybridization of the 2.5 kb mouse agt-in probe to EcoRI-digested genomic DNA resulted in the detection of an 11 kb Chinese hamster (Fig. 6, right, lane 1) and a 4 kb mouse (Fig. 6, right, lane 2) fragment. The 4 kb mouse fragment was present in the hybrid cell lines that had retained Figure 2 . Intron-exon junctions in the mouse agrin gene. The nucleotide sequence through the RNA splicing junctions of the 36 exons is presented. The nucleotides in lowercase are intron sequence, while the nucleotides in uppercase are exon sequence. Each acceptor site conforms to the AC consensus, while each donor site conforms to the GT consensus. The amino acid sequence at each of the exon borders is written above the second nucleotide of the codon, and the amino acids are numbered according to the rat agrin sequence of Rupp et al. (199 1) . The length of the rat exons in nucleotides is written between the acceptor and donor borders. Two acceptor sites are utilized for exon 20 (denoted 20~ and ZOb), and exons 32 and 33 encode the alternatively spliced regions presented in Figure 1B 
R-IHRLELSRHWRQC;rr~MGE---------TPW~~~----SGTDG~TN~~~I~ (1390) T-IWRVFLEfWG2lrC6ALODG---------PRVLOES (1664) R-WLR~RAHREHRE;OS110G~---------APVTCSS----
LGATQLDTDGA3rWL#LQ (1892) NRwHSJYITRFGN~S~5~~---SAAENPPVRTG T-WYKIAFQRNRKQOLLAVFDA---YDTSDKETKQGETPG Rupp et al. (1991) . B, R-AGRNI (amino acids 1287-1390; exons 21-22; Rupp et al., 1991) . R-AGRNZ (amino acids 1555-1664; exons 26-29) and R-AGRN3 (amino acids 1788-1892; exons 34-35) are repeated motifs. In this region, 43% of the amino acids are identical, as indicated by bold type. The underlined sequence (KSRK) in R-AGRNZ is encoded by exon 28. In the mouse laminin A chain (M-ALAMZ and A4-ALAA42), amino acids 2086-2 198 and 2273-2384 (Sasaki et al., 1988) are 32% identical, as indicated by the bold r.vpe. In human merosin (H-MRSNI, H-MRSNZ, H-MRSN3), amino acids 190-305, 384-494, and 809-911 (Ehrig et al., 1990) share identical amino acids in two of every three positions at 50% of the residues, as indicated by the bold type, and identical amino acids in all positions at 16% of the residues. The shading indicates a common core sequence shared by all of the domains in the three proteins. One-third of the residues are identical in at least four of eight positions. mouse chromosome 4. All other mouse chromosomes were excluded by at least two discordant hybrids (Table 2) . Thus, the mouse agrin gene (gene symbol Agm) can be assigned to chromosome 4.
We have searched for polymorphisms using two mouse genomicagrin DNA probes. A BamHI-BamHI fragment including exons l-6, and a HindIII-Not1 fragment including exon 36 and a region 3' to the gene (Fig. 3) . No strain differences were detected with BamHI, PstI, EcoRI, BglII, and Hind111 in five inbred mouse strains, AKR/J, C3H/HeJ, C57BL/6J, C57L/J, and DBA/2J.
Discussion
The domain structure of agrin. This report characterizes the DNA and RNA that code for mammalian agrin. The clear domain structure revealed by analysis of the predicted amino acid sequence is further revealed by the agrin genomic organization presented here. The amino terminus regions homologous to protease inhibitors are each encoded by a separate exon, suggesting that this portion of agrin evolved through a series of unequal crossover events that produced a tandem array of these units. The fact that protease inhibitor repeats 8 and 9 have an internal intron suggests one of two scenarios. First, it is possible that the original protease inhibitordomain contained this intron and that a unit that had deleted the intron was amplified, resulting in the seven amino terminal protease inhibitor domains. Alternatively, it is possible that the insertion of sequences produced an intron and that a single duplication then resulted in units 8 and 9. The first hypothesis is supported by the following observation:
the exons that encode the first half of the protease inhibitor domains 8 and 9 (exons 8 and 13, respectively) contain a sequence that resembles an EGF repeat more than a protease inhibitor domain. In many EGF repeat containing proteins, such as the EGF precursor, the LDL receptor (Siidhof et al., 1985) protein S (Schmidel et al., 1990) , and cartilage matrix protein . DNA and protein alignment of a portion of human and rat agrin cDNAs. The nucleotide sequence is numbered above for the human cDNA and below for the rat cDNA, according to Rupp et al. (199 1) . The identical nucleotides are indicated by (:), and the identical amino acids are underlined.
Twenty-nine nucleotide differences between human and rat result in nine amino acid substitutions in this region of the agrin protein.
( Kiss et al., 1989 ) the EGF repeat domains are individually encoded on separate exons. This suggests that agrin protease inhibitor domains 8 and 9 were formed by rearrangement of an EGF repeat exon and a protease inhibitor exon sequence. The model is supported by the observation that strong homology to pancreatic secretory trypsin inhibitors is on the carboxy terminal side of the intron.
The analysis of ovoinhibitor, a Kazal-type serine protease inhibitor with seven tandem inhibitor units, has revealed introns flanking the individual domains (Stein et al., 1980; Scott et al., 1987) . Thus, a common theme of internal duplication to generate tandem protease inhibitor-like units appears to have played a significant role in the evolution of both agrin and the Kazal family of proteins. Ovoinhibitor and ovomucoid also contain introns within the Kazal protease inhibitor domains. One of these introns is located four amino acids carboxy-terminal to the fifth cysteine residue of the inhibitor domain. Interestingly, while all of the agrin cysteine residues align with the Kazal inhibitor motif rather precisely, the fifth cysteine is displaced to precisely the position of this intron. Thus, rearrangement near this intron site may be responsible for the cysteine pattern present in agrin. The intervening sequences in the agrin laminin domain III homologous regions (exons 11 and 12) are found in positions similar to those of introns in domain III of the laminin A chain (Vuolteenaho et al., 1990) . This organization strongly favors the hypothesis that exon shuffling from a common progenitor has generated these domains. Agrin also contains regions that are homologous to the G domain of laminin A and merosin. The G region is a large globular domain that is proposed to bind heparin (Sakashita et al., 1980; Ott et al., 1982) . Perhaps this region of agrin is involved in the binding of heparan sulfate proteoglycans. This hypothesis is supported by the finding that an addition of heparin to the culture medium inhibits the formation of agrin-induced clusters of AChR. One of the agrin regions homologous to the laminin G domain has a basic, 4 amino acid insert that is encoded on a distinct exon. These basic amino acids may modulate the interactions with proteoglycans. It is noteworthy that the genomic organization of agrin and many other proteins containing repeated domains appears to be very similar, in that the individual repeats are encoded by independent exons. This observation supports the original proposal by Gilbert (1985 Gilbert ( , 1987 suggesting that a pool of exons encoding distinct functional and structural domains may have been shuffled during evolution to generate new proteins. In this case, it appears that shuffling of exons between extracellular matrix proteins has played a role in the evolution of these molecules. These shuffling mechanisms are likely to have been important in the evolution of the protein-protein interactions that generate the scaffold structure of the extracellular matrix.
Alternative RNA splicing. The alternative RNA splicing of the mammalian agrin gene is interesting in a variety of contexts. First, two different organizations of acceptor and donor sequences are used. While exon 20 presents two acceptor sites to the donor site of exon 19, the organization of splicing in the carboxy terminal region of the protein is quite different. Here, two independent exons are spliced in the four possible configurations. If exon 3 1 is spliced to exon 34, as most often appears to happen based on the relative abundance of cDNAs, the effective intron is about 1058 nucleotides, the largest in the gene. The two alternatively spliced regions are among the smallest exons in the gene, 24 and 33 nucleotides, respectively.
The AChR clustering activity of the four differentially spliced products at position 1779 has recently been investigated (Ferns et al., in press ). The four forms of the protein, either containing no exon sequences at position 1779 (agrin,), the 8 amino acid exon (agrin,), the 11 amino acid exon (agrin,,), or the 8 and the 11 amino acid exons (agrin,,), were expressed in CHO and COS cells. Coculture of the transfected cells with primary muscle cells or myotubes derived from the C2 muscle cell line results in AChR clusters at all cell-cell contact sites. Coculture experiments were also conducted with S27 cells, myoblasts that synthesize altered proteoglycans. Only agrin, and agrin,, are able to induce AChR clusters at contact sites on S27 derived myotubes. In addition, only agrin, and agrin,, are effective in inducing AChR clusters on chick myotubes. These studies suggest Total informative hybrids0 10 12 12 11 10 11 11 12 12 11 12 12 11 11 12 10 12 11 11 11 a Chromosomes with rearrangements or present at a frequency of 0.1 or less were excluded.
the following AChR clustering activity profile for the different forms of rat agrin: 0 2 11 < 19 I 8. Thus, the alternative RNA splicing we have described here regulates the AChR clustering activity of the agrin proteins on a variety of cultured myotubes and may also do so in vivo. We do not yet know the tissue specificity of the alternatively spliced agrin forms. For instance, agrin is expressed in brain, muscle, and areas of the spinal cord, including motor neurons. It is possible that the forms of agrin most active in AChR clustering are preferentially expressed in motor neurons. Differential splicing of agrin transcripts could also be regulated by developmental and physiological conditions. Perhaps various agrin isoforms are expressed at different stages of development, or in response to physiological changes, such as during reinnervation following nerve damage.
The agrin gene locus. Mapping of the agrin gene locus in the human and mouse genomes was undertaken to determine whether the gene is colocalized with a neuromuscular disease gene in humans or a neurological mutation in mouse. The human agrin gene (AGRN) has been mapped to the distal short arm of chromosome 1 (HSA l), bands pter-p32, by Southern blot analysis of DNA from Chinese hamster x human hybrid cell lines. So far, the only neuromuscular disorder that has been assigned to this region of chromosome 1 is the Finnish type of infantile neuronal ceroid-lipofuscinosis (Jarvela et al., 199 1) . This disorder is due to a disturbance of linoleic acid metabolism and, therefore, not a likely candidate for an agrin mutation.
The murine Agrn locus has been mapped to mouse chromosome 4 (MMU 4) with a panel of Chinese hamster x mouse hybrid lines. The human chromosome region Ipter-p32 is homologous to the distal half of MMU 4. There are 14 other homologous genes in these regions (see Davisson et al., 1990 , for review). There are three neurological mutations on MMU 4 in the conserved region that could involve Agrn. In cribriform degeneration (cri), homozygotes have abnormal behavior, anemia, and electrolyte imbalance. Severe vacuolar degeneration is present in white and gray matter of brainstem, spinal cord, and retina (Green et al., 1972) . The recessive mutationjetierker) is associated with hyperactivity, circling, head tossing, deafness, and postnatal degeneration of the sensory cells of the cochlea, sacculus, and utriculus (Griineberg et al., 194 1; Deol, 1954; Steel and Bock, 1983) . Another recessive mutation, cla (clasper), is characterized by small size, fine body tremor, and clasping of forefeet and hindfeet (Sweet, 1985) . Before embarking on any direct mutational analysis, it will be necessary to map the mouse Agrn locus more precisely by using interspecies crosses, since no polymorphism was detected in progenitor strains of common RI strains.
Characterization of the mammalian agrin gene presented here is the beginning of a new era in understanding the function of this protein. We are now in a position to use mouse genetics and transgenic techniques to evaluate further the function of agrin in synapse development and disease states.
